Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Comella

Showing results (521-530 of 685) with videos related to

Pageof 69
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 17, 2023
Alkalihalobacillus clausii (formerly Bacillus clausii) spores lessen antibiotic-induced intestinal injury and reshape gut microbiota composition in miceC Pirozzi, N Opallo, L Coretti, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 9, 2010
Scales to assess sleep impairment in Parkinson's disease: critique and recommendationsBirgit Högl, Isabelle Arnulf, Cynthia Comella, et al.
The Lancet. Neurology|June 4, 2013
Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trialAnthony H V Schapira, Michael P McDermott, Paolo Barone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancerX Pivot, A Awada, D Gedouin, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 15, 2016
Reelin Regulates the Maturation of Dendritic Spines, Synaptogenesis and Glial Ensheathment of Newborn Granule CellsCarles Bosch, Nuria Masachs, David Exposito-Alonso, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|May 7, 2019
Combining magnetic nanoparticles and icosahedral boron clusters in biocompatible inorganic nanohybrids for cancer therapyElena Oleshkevich, Anna Morancho, Arpita Saha, et al.
Clinical Parkinsonism & Related Disorders|March 25, 2022
Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority studyCynthia Comella, Robert A Hauser, Stuart H Isaacson, et al.
Neurology|February 1, 1990
Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor dataC G Goetz, C M Tanner, R D Penn, et al.
Oncology Reports|January 12, 2005
Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urotheliumVito Lorusso, Enrico Crucitta, Nicola Silvestris, et al.
Journal of Chemotherapy (Florence, Italy)|February 11, 2005
Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer: a prospective, randomized phase III trial of the Italian Society for Integrated Locoregional Therapy in OncologyM Cantore, G Fiorentini, G Luppi, et al.
Pageof 69

Showing results (521-530 of 685) with videos related to

Sort By:
Pageof 69
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 17, 2023
Alkalihalobacillus clausii (formerly Bacillus clausii) spores lessen antibiotic-induced intestinal injury and reshape gut microbiota composition in miceC Pirozzi, N Opallo, L Coretti, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 9, 2010
Scales to assess sleep impairment in Parkinson's disease: critique and recommendationsBirgit Högl, Isabelle Arnulf, Cynthia Comella, et al.
The Lancet. Neurology|June 4, 2013
Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trialAnthony H V Schapira, Michael P McDermott, Paolo Barone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancerX Pivot, A Awada, D Gedouin, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 15, 2016
Reelin Regulates the Maturation of Dendritic Spines, Synaptogenesis and Glial Ensheathment of Newborn Granule CellsCarles Bosch, Nuria Masachs, David Exposito-Alonso, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|May 7, 2019
Combining magnetic nanoparticles and icosahedral boron clusters in biocompatible inorganic nanohybrids for cancer therapyElena Oleshkevich, Anna Morancho, Arpita Saha, et al.
Clinical Parkinsonism & Related Disorders|March 25, 2022
Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority studyCynthia Comella, Robert A Hauser, Stuart H Isaacson, et al.
Neurology|February 1, 1990
Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor dataC G Goetz, C M Tanner, R D Penn, et al.
Oncology Reports|January 12, 2005
Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urotheliumVito Lorusso, Enrico Crucitta, Nicola Silvestris, et al.
Journal of Chemotherapy (Florence, Italy)|February 11, 2005
Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer: a prospective, randomized phase III trial of the Italian Society for Integrated Locoregional Therapy in OncologyM Cantore, G Fiorentini, G Luppi, et al.
Pageof 69